Search research articles
Contact Us
Filters
Showing results (311-320 of 583) with videos related to
Page
of 59
Sort By:
Cancer
|
March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B
R Mir, J Anderson, J Strauchen, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
July 7, 2011
Cancer screening practices among Amish and non-Amish adults living in Ohio Appalachia
Mira L Katz, Amy K Ferketich, Electra D Paskett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
K Virtaneva, F A Wright, S M Tanner, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group B
D B Duggan, M T Santarelli, K Zamkoff, et al.
Leukemia & Lymphoma
|
May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107
Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy
M Wetzler, M R Baer, S H Bernstein, et al.
Blood
|
March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies
R E Sobol, I Royston, T W LeBien, et al.
Leukemia
|
April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry
M R Baer, C C Stewart, D Lawrence, et al.
Cancer
|
April 1, 1982
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804
S J Ginsberg, S T Crooke, C D Bloomfield, et al.
Haematologica
|
July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)
Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Page
of 59
Search research articles
Search
Showing results (311-320 of 583) with videos related to
Sort By:
Page
of 59
Cancer
|
March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B
R Mir, J Anderson, J Strauchen, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
July 7, 2011
Cancer screening practices among Amish and non-Amish adults living in Ohio Appalachia
Mira L Katz, Amy K Ferketich, Electra D Paskett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
K Virtaneva, F A Wright, S M Tanner, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group B
D B Duggan, M T Santarelli, K Zamkoff, et al.
Leukemia & Lymphoma
|
May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107
Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy
M Wetzler, M R Baer, S H Bernstein, et al.
Blood
|
March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies
R E Sobol, I Royston, T W LeBien, et al.
Leukemia
|
April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry
M R Baer, C C Stewart, D Lawrence, et al.
Cancer
|
April 1, 1982
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804
S J Ginsberg, S T Crooke, C D Bloomfield, et al.
Haematologica
|
July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)
Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Page
of 59